Search

Guangdong has released guidelines for manufacturing and high-tech enterprises to apply for loan interest subsidies. Eligible loans obtained between May 1, 2025 and December 31, 2027 may receive up to 20 million yuan in annual subsidies per enterprise. 

Guangdong's foreign exchange authority issued QFLP pilot rules in September 2025, adding Hengqin as a new pilot zone. The policy introduces quota management, simplified forex registration and better cross-border currency conversion to facilitate investment and financing.

As global investors increasingly seek renminbi-denominated products, Hong Kong's role as the world's offshore renminbi hub and risk management center is growing. With strong national backing, the government is deepening financial connectivity with the mainland. It is also expanding the range of renminbi investment and risk management tools to meet investor needs.

the deepening biomedical collaboration between Hong Kong and Shenzhen, highlighting the pivotal role of the Hetao Cooperation Zone. It showcases how companies leverage Hong Kong's international resources and Shenzhen's manufacturing strength for joint R&D and global market expansion, with policy support facilitating cross-border flows of data, talent, and capital.

Hong Kong's pivotal role in advancing biomedical innovation within the Guangdong-Hong Kong-Macao Greater Bay Area (GBA). Leveraging its strengths in international finance, regulatory frameworks like the "1+ mechanism," and world-class research, Hong Kong collaborates with mainland cities to drive industry upgrades, support startups, and attract global investments, positioning the GBA as a leading biotech hub.

On September 25, the People's Bank of China announced new measures to deepen financial connectivity between the mainland and Hong Kong. These include supporting foreign investors in mainland bond repos, expanding the "Swap Connect" program, doubling the daily quota for "Northbound Connect" to RMB 45 billion, and increasing the supply of RMB assets in Hong Kong.

Foshan has implemented the nation's first prefecture-level city government regulation dedicated to promoting corporate investment. The regulation aims to create a first-class business environment characterized by market-oriented, rule-of-law, and internationalized standards through measures including attracting and facilitating investment, optimizing investment services, and equally protecting the lawful rights and interests of all types of investors.

Chief Executive Mr John Lee stated the HKSAR Government will deepen rules alignment and mechanism connectivity among Guangdong, Hong Kong and Macao. The initiative aims to enhance cross-boundary flows of people, goods, data, and capital, including measures to optimise cross-border credit referencing and payment systems.

A Chinese official announced that the Greater Bay Area is now a top global innovation cluster, forming a national innovation pattern with Beijing and Shanghai.

On September 4, China's Ministry of Industry and Information Technology and State Administration for Market Regulation released an action plan targeting 7% annual growth in industrial added value for the electronic information manufacturing sector (2025-2026). The plan prioritizes 6G, photovoltaics, and lithium batteries, with the goal of establishing five trillion-yuan provincial industrial clusters by 2026.

New rules for importing urgently needed Hong Kong and Macao medical products into the Greater Bay Area were announced on September 15, effective November 1, 2025.

On September 16, Guangdong province issued an action plan (2025-2027) to boost its toy industry with AI. The plan will use provincial funds to support key AI projects and equipment upgrades. Eligible companies, including specialized SMEs, will receive subsidies and loan interest support.

On September 15, Guangdong introduced new rules enabling Greater Bay Area hospitals to use urgently needed Hong Kong and Macao medical products. The policy now covers 45 hospitals with 125 approved products, benefiting over 10,000 patients.

HKTDC Report September 15 Hong Kongs biopharmaceutical sector grew nearly 30 percent in the past decade with over 3000 enterprises and with new Guangdong policies the Greater Bay Area is expected to see major business opportunities in this industry

Seven state agencies, including the People’s Bank of China, have jointly issued a guideline for developing a financial system to support the advancement of new industrialisation. The guideline calls for providing financing in the form of loans, bonds and equity. This will be achieved through 18 measures, including the optimisation of financial policy tools, the attraction of long-term funds and the development of patient capital.